Laing N G, Wilton S D, Akkari P A, Dorosz S, Boundy K, Kneebone C, Blumbergs P, White S, Watkins H, Love D R
Australian Neuromuscular Research Institute, Department of Pathology, University of Western Australia.
Nat Genet. 1995 Jan;9(1):75-9. doi: 10.1038/ng0195-75.
Nemaline myopathies are diseases characterized by the presence in muscle fibres of pathognomonic rod bodies. These are composed largely of alpha-actinin and actin. We have identified a missense mutation in the alpha-tropomyosin gene, TPM3, which segregates completely with the disease in a family whose autosomal dominant nemaline myopathy we had previously localized to chromosome 1p13-q25. The mutation substitutes an arginine residue for a highly conserved methionine in a putative actin-binding site near the N terminus of the alpha-tropomyosin. The mutation may strengthen tropomyosin - actin binding, leading to rod body formation, by adding a further basic residue to the postulated actin-binding motif.
杆状体肌病是以肌纤维中存在特征性杆状体为特点的疾病。这些杆状体主要由α-辅肌动蛋白和肌动蛋白组成。我们在α-原肌球蛋白基因TPM3中鉴定出一个错义突变,在一个常染色体显性杆状体肌病家系中,该突变与疾病完全共分离,此前我们已将该家系的常染色体显性杆状体肌病定位于1p13-q25染色体区域。该突变在α-原肌球蛋白N端附近一个假定的肌动蛋白结合位点,用一个精氨酸残基替代了一个高度保守甲硫氨酸。该突变可能通过在假定的肌动蛋白结合基序上增加另一个碱性残基,增强原肌球蛋白与肌动蛋白的结合,从而导致杆状体形成。